HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malaria parasite sequences from chimpanzee support the co-speciation hypothesis for the origin of virulent human malaria (Plasmodium falciparum).

Abstract
Phylogenetic analyses of the mitochondrial cytochrome b (cytb), apicoplast caseinolytic protease C (clpC), and 18S rRNA sequences of Plasmodium isolates from chimpanzees along with those of the virulent human malaria parasite P. falciparum showed that the common chimpanzee (Pan troglodytes) malaria parasites, assigned by Rich et al. (2009) to P. reichenowi, constitute a paraphyletic assemblage. The assumption that P. falciparum diverged from P. reichenowi as recently as 5000-50,000 years ago would require a rate of synonymous substitution/site/year in cytb and clpC on the order of 10(-5)-10(-6), several orders of magnitude higher than any known from eukaryotic organelle genomes, and would imply an unrealistically recent timing of the most recent common ancestor of P. falciparum mitochondrial genomes. The available data are thus most consistent with the hypothesis that P. reichenowi (in the strict sense) and P. falciparum co-speciated with their hosts about 5-7 million years ago.
AuthorsAustin L Hughes, Federica Verra
JournalMolecular phylogenetics and evolution (Mol Phylogenet Evol) Vol. 57 Issue 1 Pg. 135-43 (Oct 2010) ISSN: 1095-9513 [Electronic] United States
PMID20541613 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright 2010 Elsevier Inc. All rights reserved.
Chemical References
  • DNA, Mitochondrial
  • DNA, Protozoan
  • RNA, Ribosomal, 18S
  • Cytochromes b
Topics
  • Animals
  • Cytochromes b (genetics)
  • DNA, Mitochondrial (genetics)
  • DNA, Protozoan (genetics)
  • Genetic Speciation
  • Genome, Mitochondrial
  • Host-Parasite Interactions
  • Pan troglodytes (parasitology)
  • Phylogeny
  • Plasmodium falciparum (classification, genetics)
  • RNA, Ribosomal, 18S (genetics)
  • Sequence Alignment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: